Home
OrbiMed Capital GP VI, Director: ARS Pharmaceuticals SPRY Buy · Filed 23/08/31
Trade details
- Type
- Insider buy
- Amount
- $3,100,000
- Shares · price
- 500,000 sh · $6.20 a share
- Held after
- 8,019,187 sh
- Trade date
- 23/08/29
- Filed
- 23/08/31
- Days to filing
- 2 days
9 insiders bought this week
- Insiders buying this week
- 9 insiders
- Holding change
- +6.6%
ARS Pharmaceuticals trades, last 26 weeks
What else happened in ARS Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 23/07/30~23/09/28OrbiMed Capital GP VI's recent trades
- OrbiMed Capital GP VI
BuyPrelude Therapeutics
BuyPrelude Therapeutics
PRLD
$7.5M
1,689,189 sh
$7.5M
Filed 04/23
Traded 04/21
- OrbiMed Capital GP VI
BuyPrelude Therapeutics
BuyPrelude Therapeutics
PRLD
$5M
1,126,126 sh
$5M
Filed 04/23
Traded 04/21
- OrbiMed Capital GP VI
SellAdicet Bio
SellAdicet Bio
ACET
$263.5K
40,416 sh
$263.5K
Filed 04/09
Traded 04/08
- OrbiMed Capital GP VI
SellAdicet Bio
SellAdicet Bio
ACET
$204.6K
32,523 sh
$204.6K
Filed 04/09
Traded 04/08
- OrbiMed Capital GP VI
SellAdicet Bio
SellAdicet Bio
ACET
$191.5K
29,319 sh
$191.5K
Filed 04/09
Traded 04/07
